tm logo
Trademark Search
PLEXZYME

View On IC.GC.CA

PLEXZYME
REGISTERED

on 12 Sep 2019

Last Applicant/ Owned by

SPEEDX PTY LTD

Se G16 National Innovation CentreAustralian Technology Park4 Cornwallis StreetEveleigh, New South Wales 2015

AU

Serial Number

1762179 filed on 06th Jan 2016

Registration Number

TMA1053910 registered on 12th Sep 2019

Registration expiry Date

12th Sep 2029

Correspondent Address

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

CA

M4T1X3

PLEXZYME

Trademark usage description

chemicals used in science being primers and chemical preparations for scientific purposes (other than for medical or veterinary use), namely for in vi Read More

Classification Information

Class [001]
Chemicals used in science being primers and chemical preparations for scientific purposes (other than for medical or veterinary use), namely for in vitro use in biochemistry, clinical chemistry and microbiology, photography, agriculture, horticulture and forestry; reagents and reactants other than for medical or veterinary purpose, namely diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Enzymes for industrial purposes, namely for diagnostic testing purposes in the field of in vitro diagnostic use namely, for use in the diagnosis of diseases or detection or identification of pathogens; nucleic acids for laboratory use and diagnostic testing purposes; nucleic recombinant acids; acids being inorganic and organic acids being for vitro use in biochemistry, clinical chemistry, microbiology and diagnostic testing purposes; polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring being chemicals for the control of environmental pollution, reagents for use in environmental analysis, reagents for use in environmental testing.

Classification kind code

10

Class [005]
Pharmaceutical and veterinary preparations and substances being preparation and substances comprising of nucleic acid sequences for diagnostic and therapeutic use, including in vitro diagnostic use, namely, for use in the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use being reagents comprising of nucleic acid sequences for diagnostic and therapeutic use, including diagnostic use, namely, for use in the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; nucleic acid sequencing reagents for medical use for diagnostic and therapeutic use, including in vitro diagnostic use; Chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; Chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for diagnostic and therapeutic use, including diagnostic use, for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes, for diagnostic and therapeutic use, including diagnostic use, for the diagnosis of diseases or detection or identification of pathogens; Medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; Clinical diagnostics for medical and veterinary use using nucleic acid sequences, including in vitro diagnostic use, namely, for use in the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders.

Classification kind code

10

Class [010]
Apparatus and instruments namely amplification controls quantitative polymerase chain reaction tests for use in relation to surgery, for veterinary use, for medical diagnostic and therapeutic use namely gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Diagnostic testing apparatus containing biomarker reagents for use in gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; Diagnostic testing kits containing biomarker reagents for use in gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Point of care medical devices namely amplification controls quantitative polymerase chain reaction tests for gene therapy use, namely in relation to gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; Screening kits namely amplification controls quantitative polymerase chain reaction tests for use in relation to gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders.

Classification kind code

10

Mark Details

Serial Number

1762179

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 21st Feb 2019		Approved
Submitted for opposition 27
on 03rd Jan 2019		Approval Notice Sent
Submitted for opposition 15
on 04th Jun 2018		Correspondence Created
Submitted for opposition 15
on 12th Oct 2017		Correspondence Created
Submitted for opposition 15
on 09th Jan 2017		Correspondence Created
Submitted for opposition 22
on 02th Jun 2016		Search Recorded
Submitted for opposition 20
on 02th Jun 2016		Examiner's First Report
Submitted for opposition 1
on 07th Jan 2016		Created
Submitted for opposition 31
on 07th Jan 2016		Formalized
Submitted for opposition 30
on 06th Jan 2016		Filed